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INTRODUCTION
Skin acts as a barrier to protect the body from the external envi-
ronment, and it also serves to prevent water loss from the body. 
When a full-thickness skin defect occurs, a full-thickness skin 
graft (FTSG) or local flap is typically used for reconstruction. 
However, for coverage of a large-sized defect, the dermis can 
only be reconstructed using a split-thickness skin graft (STSG) 
rather than a full-thickness skin graft.
Wound healing is a process that proceeds gradually and ulti-
mately aims to recover the skin barrier. This process is complex 
and involves a variety of cells [1]. The dermis of the damaged 
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skin is either replaced by scar tissue that epithelializes to form 
wound borders, or an STSG is used to close the wound. The 
amount and arrangement of dermal elastic fibers have great ef-
fects on restored skin quality [2,3]. However, patchy dermal 
remnants of the dermal papillae provided by the STSG do not 
result in a healthy dermal layer for the wound [3]. As a result, 
STSG provides unsatisfactory results, such as scar contraction 
and scarring. In this process, reconstruction of the dermis plays 
an important role in the recovery of wounds, in particular [1,4,5].
However, autologous skin grafts have some limitations, which 
include undesirable functional and cosmetic outcomes that re-
sult from hypertrophic scars, poor skin elasticity, and limitations 
in joint movement due to scar contracture. To complement the 
drawbacks of STSG, various alternative dermal substitutes, such 
as acellular dermis or artificial dermal matrix, have been devel-
oped and have been applied in the treatment of full-thickness 
skin defects [3,6-8].
One of the popular dermal substitutes of alternative dermis is 
acellular dermal matrix. AlloDerm (LifeCell Corp., Branchburg, 
NJ, USA) is the most widely used acellular dermal matrix. It is a 
freeze-dried product that is obtained from cadaveric skin and al-
lows improvement in the structure of the dermis. This improve-
ment contributes to wound healing and reduces scar contracture 
[9-11]. Because this product contains elastin and collagen, it re-
duces tension and increases the elasticity of the newly formed 
skin of the restored wound. As a result, contraction of the wound 
does not occur. As a result, this product improves the functional-
ity and aesthetics of skin grafts [12]. However, there are some 
limitations to the use of human-derived skin products. Because 
these are processed from donated human tissue, there could be 
limits to the supply quantity, leading to an economic burden for 
disadvantaged patients [13]. Artificial dermis has been widely 
used to overcome the shortcomings of acellular dermal matrix 
and to cover full-thickness large skin defects. Artificial dermis re-
duces scar contraction of the skin graft site and provides skin 
quality with optimized elasticity and flexibility [6].
Matriderm (MedSkin Solution Dr. Suwelack AG, Billerbeck, 
Germany) is a highly porous membrane composed of three-di-
mensionally coupled collagen and elastin. The collagen of the 
matrix is obtained from the bovine dermis, and the elastin is ob-
tained from the bovine nuchal ligament by hydrolysis. Matri-
derm provides a scaffold to restore the skin and modulates scar 
formation. Matriderm reduces the risk of hematoma that occurs 
after skin grafting due to its hemostatic properties. There are 
many reports of successful engraftment through a one-step pro-
cedure using Matriderm and skin grafting in vitro [14], in vivo 
[15-18] and in clinical trials [19].
To investigate the usefulness of Matriderm as a sufficient der-
mal substitute, we analyzed the survival rate of skin grafts when 
performed using one-stage grafting with Matriderm and STSG 
on full-thickness skin defect wounds of various types. We also 
analyzed the quality of the grafted skin by comparing the elastic-
ity, transdermal water loss, and the erythema and melanin levels 
of both the adjacent normal skin and the grafted area. 
METHODS
Between January 2010 and March 2012, a retrospective review of 
patients who had undergone skin grafts with Matriderm for full-
thickness skin defects at Severance Hospital was performed. This 
study was undertaken with permission from the institutional re-
view board of Yonsei University College of Medicine. A total of 
31 patients who had undergone skin grafts using Matriderm for 
full-thickness skin defects were enrolled in this study. We con-
ducted a retrospective chart analysis of patient gender, age, injury 
mechanism, site, and defect size. The survival rate of the skin graft 
was defined as the percentage of the entire graft that was consid-
ered to be stable and that was well-adhered to the wound bed 7 to 
10 days after surgery. The transplantation was rated successful 
when more than 90% of the grafted surface area was stable.
In the surgical procedure, the dermal substitute (Matriderm) 
was applied to the prepared wound bed and soaked in a 0.9% sa-
line solution after hemostasis of the full-thickness skin defect 
wound had been achieved. Autologous 1:1.5 meshed skin was 
grafted over the dermal substitute. The split-thickness skin graft 
was fixed with staplers or non-absorbable sutures. At the end of 
surgery, a vacuum-assisted therapy (VAC) device with an inter-
mittent negative pressure of 125 mm Hg was applied to prevent 
the formation of a seroma and to reduce shearing forces on the 
skin grafts. The VAC device was removed when the dressing was 
exchanged for the first time on the fourth postoperative day.
Evaluation tools
To objectively investigate skin quality, we measured four param-
eters (skin elasticity, humidification, trans-epidermal water loss, 
and the melanin and erythema levels) and compared the skin 
quality of the Matriderm and the skin graft area with the adja-
cent normal skin starting six months after surgery.
The elasticity of the skin was measured using a Cutometer 
SEM 580 (Courage-Khazaka Electronic GmbH, Cologne, Ger-
many). This device pulled the skin using negative pressure 
through an 8 mm-diameter probe and measured the elasticity. 
The degree of elasticity was defined as the maximum value that 
the skin was distorted by the device. A Corneometer CM 825 
(Courage-Khazaka Electronic GmbH) evaluated the humidifi-
cation of the skin by measuring the capacitance of the surface of 
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the skin. Trans-epidermal water loss was determined by a 
Tewameter (Courage-Khazaka Electronic GmbH), which mea-
sured the water evaporation. This value indicated the barrier 
power of the skin. A Mexameter MX 18 (Courage-Khazaka 
Electronic GmbH) was utilized, and a ‘photo spectrum analysis’ 
principle was applied to measure the melanin levels and the ery-
thema of the skin. Higher levels of melanin and erythema were 
represented by darker and redder skin [11,20,21]. These objec-
tive skin quality values were analyzed with the StatView Package 
(SPSS Inc., Chicago, IL, USA) using the Wilcoxon signed-rank 
test. Statistical significance was assumed if a P-value was less than 
0.05. All the results are shown as median (interquartile range).
RESULTS
A total of 31 patients were grafted with Matriderm and STSG 
(Table 1). The patients consisted of 20 men and 11 women be-
tween the ages of 4 and 68 years. The mean age was 43.32 ±  
19.28 years. Causes of the defects included donor site for a fore-
arm free flap (n = 16, 51.61%), correction of scar contracture 
(n = 4, 12.9%), crushing injury (n = 4, 12.9%), third-degree burn 
(n = 2, 6.45%), surgical correction of nevus (n = 2, 6.45%) or ke-
loid (n = 1, 3.2%), Diabetes mellitus (DM) foot (n = 1, 3.2%), 
and osteomyelitis (n = 1, 3.2%). The size of the defects ranged 
from 12.5 to 180 cm2, and the mean area was 75.06 cm2. The 
mean follow-up was 12 months (range, 6–32 months).
Skin grafted with Matriderm using a single-stage procedure 
was transplanted successfully without infection or inflammatory 
response in all cases but one, which resulted in a seroma. Al-
though showing a partial loss of 40% in this one case, the wound 
was epithelized within two weeks without additional grafting. 
As a result, the overall survival rate of the matrix and the skin 
graft in this study group was 96.7%.
The quality of the grafted skin with Matriderm was measured 
in a total 16 of 31 patients who authorized an examination to 
evaluate skin quality. To evaluate the skin quality objectively, 
four measurement items were adopted: 1) skin elasticity, 2) hy-
dration, 3) skin barrier, and 4) darkness and redness using the 
Table 1. Patient information 
No. Sex Age (yr) Cause of defect Defect area Defect size (cm2) Graft take Complication
1 M 60 Osteomyelitis Lower leg, Lt. 12.5 Stable None
2 M 36 Burn (3rd degree) 4th, 5th MPJ & finger, Rt. 20 Stable None
3 M 67 Donor site Forearm, Lt. 28 Stable None
4 F 4 Postoperative scar contracture Foot, Rt. 30 Stable None
5 F 44 Crushing injury Knee, Lt. 30 Stable None
6 M 9 Postoperative scar contracture Foot, Lt. 35 Stable None
7 F 45 Crushing injury Inguinal area, Lt. 35 Stable None
8 F 58 Donor site Forearm, Lt. 40 Stable None
9 F 38 Donor site Forearm, Lt. 45 Stable None
10 F 68 Donor site Forearm, Lt. 48 Stable None
11 F 25 Donor site Forearm, Lt. 50 Stable None
12 M 51 Crushing injury Lower leg, Lt. 50 Stable None
13 M 55 Donor site Forearm, Lt. 50 Stable None
14 M 45 Donor site Forearm, Lt. 60 Stable None
15 M 54 Donor site Forearm, Lt. 72 Stable None
16 F 24 Crushing injury Lower leg, Rt. 75 Stable None
17 M 58 Donor site Forearm, Lt. 80 Stable None
18 M 63 Donor site Forearm, Lt. 80 Stable None
19 M 54 Donor site Forearm, Rt. 88 Stable None
20 M 55 Donor site Forearm, Lt. 120 Stable None
21 M 53 DM foot Lower leg, Rt. 150 Stable None
22 M 15 Scar contracture Forearm, Rt. 150 Stable None
23 M 29 Keloid Neck 150 Stable None
24 F 25 Giant hairy nevus Forearm, Lt. 150 Stable None
25 M 63 Burn (3rd degree) Foot, Lt. 150 Stable None
26 M 9 Scar contracture Upper arm to cubital fossa, Rt. 171 Stable None
27 F 13 Giant hairy nevus Forearm, Rt. 180 Unstable (40%) Seroma
28 M 43 Donor site Forearm, Lt. 63 Stable None
29 M 63 Donor site Forearm, Lt. 58.5 Stable None
30 M 54 Donor site Forearm, Lt. 28 Stable None
31 F 63 Donor site Forearm, Rt. 28 Stable None
Lt., left; MPJ, metatarsophalangeal joint; Rt., right; DM, diabetes mellitus.
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Cutometer, Corneometer, Tewameter, and Mexameter, respec-
tively. We analyzed skin conditions by comparing the values be-
tween the grafted skin and the surrounding normal skin. The 
skin elasticity for the Matriderm area was 0.765 (range, 0.635–
0.800) and for the surrounding normal area was 0.740 (range, 
0.665–0.833) (P = 0.518). Skin humidification for the Matri-
derm area was 24.0 (range, 15.5–30.0) and for the surrounding 
normal area was 36.5 (range, 33.0–41.5), which was significant-
ly different (P = 0.001). Trans-epidermal water loss for the Mat-
riderm area was 10.0 g/hr/m2 (range, 8.15–11.00 g/hr/m2) and 
for the surrounding normal area was 10.0 g/hr/m2 (range, 
8.00–13.00 g/hr/m2) (P = 0.669). The melanin level of the 
Matriderm area was 211.0 arbitrary unit (AU) (range, 158.25–
297.00 AU), and that of the surrounding normal area was 167.0 
AU (range, 143.75–214.75) AU, demonstrating a statistically 
significant difference (P = 0.020). The erythema level of the 
Matriderm area was 352.0 AU (range, 299.25–402.75 AU), 
whereas that of the surrounding normal area was 277.0 AU 
(range, 212.25–312.25 AU) (P = 0.001) (Table 2).
Case 1 (patient no. 9)
A 38-year-old woman was diagnosed with tongue cancer and 
received a hemiglossectomy. A tongue reconstruction was per-
formed using a radial forearm free flap, leaving a defect 90 × 50 
mm in size (Fig. 1A). A dermal substitute was applied to the de-
fect site (Fig. 1B). After six months, the graft area was stable 
without any complication and with a good cosmetic outcome 
(Fig. 1C). On skin analysis, the values for elasticity, humidifica-
Fig. 1. Application of Matriderm on the forearm 
(A) A donor site undergoing radial forearm free flap to reconstruct 
the tongue. The donor site for the free flap was from a 38-year-old 
female patient who was diagnoed tongue cancer. (B) The dermal 
substitute was applied on the donor elevation site. (C) After six 
months, the graft area was stable without any complications and 
demonstrated a good cosmetic outcome. On skin analysis, the val-
ues for elasticity, humidification, skin barrier and melanin/erythema 
level of the grafted skin were 0.63, 22, 9.6 g/hr/m2, and 165/356 ar-
bitrary unit, respectively.
A
B C
Table 2. Skin assessment results
Variable Matriderm area Adjacent area P-value
Elasticity 0.765 (0.635–0.800) 0.740 (0.665–0.833) 0.518
Humidification 24.0 (15.5–30.0) 36.5 (33.0–41.5) 0.001a)
TEWL (g/hr/m2) 10.0 (8.15–11.00) 10.0 (8.00–13.00) 0.669
Melanin value 
   (AU)
211.0 (158.25–297.00) 167.0 (143.75–214.75) 0.020a)
Erythema value 
   (AU)
352.0 (299.25–402.75) 277.0 (212.25–312.25) 0.001a)
Values are presented as as median (interquartile range).
TEWL, trans-epidermal water loss; AU, arbitrary unit.
a)P<0.05.
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tion, skin barrier and melanin/erythema levels of the grafted 
skin were 0.63, 22, 9.6 g/hr/m2, and 165/356 AU, respectively. 
The values of the elasticity, humidification, skin barrier and 
melanin/erythema level of the surrounding normal area were 
0.77, 33, 6.8 g/hr/m2, and 120/214 AU, respectively.
Case 2 (patient no. 25)
A 63-year-old man sustained a third-degree scalding burn in-
volving his left foot (Fig. 2A). After performing debridement, 
the dermal substitute was applied to the wound (Fig. 2B). Ten 
months postoperatively, the incorporation of the graft and the 
aesthetic outcomes were good (Fig. 2C). On skin analysis, the 
values of the elasticity, humidification, skin barrier and melanin/
erythema levels of the grafted skin were 0.82, 29, 10 g/hr/m2, 
and 334/405 AU, respectively. The values of the elasticity, hu-
midification, skin barrier and melanin/erythema levels of the 
surrounding normal area were 0.75, 51, 9 g/hr/m2, and 214/351 
AU, respectively.
DISCUSSION
The purpose of this study was to determine the survival rate of 
the skin graft in combination with Matriderm and to analyze 
objectively whether the quality of the grafted skin was of similar 
quality to the surrounding normal skin via various parameters. 
There are several methods for coverage of full-thickness skin 
defects, such as full-thickness skin grafts or flap transposition. 
The most reliable methods for reconstruction of large defects 
are STSG [22]. However, the major limitation of STSG is its 
undesirable functional and cosmetic results, which are due to 
hypertrophic scarring, poor skin elasticity, and limitations of 
joint movement due to scar contractures. In addition, the donor 
site is insufficient for coverage of large wounds, such as major 
burns, and morbidity at the donor site is increased. Therefore, 
alternative dermal matrix has been developed to compensate for 
the disadvantages of STSG [12,22].
AlloDerm (LifeCell Corp.) is a lyophilized extracellular matrix 
obtained from cadaveric skin. Its usefulness is widely recog-
nized, but there are drawbacks, such as unstable supply and high 
Fig. 2. Application of Matriderm on the foot
(A) A soft tissue defect of the foot of a 63-year-old male patient 
who sustained a scalding burn. (B) The dermal substitute was ap-
plied to the wound. (C) Postoperative ten months, the incorporation 
and aesthetic outcome of the graft were good. On skin analysis, the 
values for elasticity, humidification, skin barrier and melanin/ery-
thema level of the grafted skin were 0.82, 29, 10 g/hr/m2, and 
334/405 arbitrary unit, respectively.
A
B C
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cost. There are various artificial dermal matrices corresponding 
to acellular matrices, such as AlloDerm; in this study, the au-
thors used Matriderm. Matriderm is a single laminar matrix 
consisting of a native (non-cross-linked) collagen matrix supple-
mented by an elastin hydrolysate. Matriderm is sterilized by 
gamma irradiation after freeze-drying and is stored at room 
temperature. In addition, unlike other artificial dermal matrices 
previously used, successful engraftment using Matriderm and a 
one-step skin-grafting procedure has been reported in vitro [14], 
in vivo [15-18] and in clinical trials [19]. In our results, the sur-
vival rate was 96.77%, and this result was the same level as a 
study using an alternative dermal matrix [1,6]. These results 
suggest that Matriderm does not a significant negative influence 
the survival rate of a skin graft and can be reliably and feasibly 
used clinically.
The elasticity of the skin with Matriderm was not significantly 
different from that of surrounding normal skin. This result indi-
cates that grafted skin in combination with Matriderm has an 
elasticity similar to normal skin. The trans-epidermal water loss 
was measured using a Tewameter to evaluate the skin barrier. 
The value of skin barrier where the Matriderm was applied was 
similar to that of the surrounding normal skin, showing that the 
Matriderm had a positive effect on skin protection. However, 
when the degree of skin darkness was assessed by measuring the 
values of melanin and erythema, the value of the melanin in the 
Matriderm area was significantly different from that of the sur-
rounding normal skin. In addition, the level of erythema was in-
creased in the Matriderm area, indicating that the Matriderm 
had a weak effect on decreasing redness. The value of skin hu-
midification was assessed by a Corneomete and also showed a 
significant difference between the Matriderm area and the nor-
mal area, demonstrating the limited effect of Matriderm on im-
proved skin humidification.
Matriderm promotes the regeneration of dermis as a scaffold 
and consequently decreases scar tissue formation. It also pro-
vides optimal dermal wound bed preparation as regenerated 
skin with extensive formation of rete ridges and capillary loops 
[23,24]. Therefore, the elasticity and skin barrier of the Matri-
derm area are close to those of the normal surrounding skin.
Recently, many studies of grafted skin have used an inspector’s 
observation of the external appearance and elasticity of the skin. 
However, these inspections lack objectivity. In addition to the 
devices mentioned above, many new objective parameters have 
been introduced [21,25]. A long-term study to observe the 
changes and condition of skin after grafting is needed to provide 
important research data for improving skin condition. This 
study demonstrates the role of Matriderm and skin graft in tis-
sue regeneration. A more objective study would include a clear-
er distinction between the Matriderm applied area and non-ap-
plied area. In treatment of a full thickness wound, Matriderm 
with an autologous skin graft involves using Matriderm for just a 
portion of the wound. In this case, when comparing the value of 
the skin assessment in each area, we would be better able to as-
sess whether the Matriderm had a positive effect on improving 
graft survival and skin quality.
Matriderm was manageable and did not require an additional 
procedure during the healing period. The use of this matrix in 
combination with skin graft resulted in a stable wound and pro-
vided promising results in our study. Moreover, the skin elastici-
ty, skin barrier, and skin color of the area over which Matriderm 
was applied were comparable to those of the adjacent normal 
skin. Therefore, we consider Matriderm to be a good dermal 
substitute for full-thickness skin defects.
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